Search terms
Results 1 - 10 of 133 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 14

Abstract Sudden cardiac death, which is mainly associated with the presence of life-threatening ventricular arrhythmias, is a common killer among patients with coronary artery disease. [...]atrial ...

Cardiovascular Research, Review, M.S. Kostapanos, E.N. Liberopoulos, J.A. Goudevenos, D.P. Mikhailidis, M.S. Elisaf

Date : 01/07/2007 Item size : 443130 bytes

Eduard Guasch, Lluís Mont Arrhythmia Unit, Unitat de Fibril·lació Auricular, Hospital Clínic, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer ...

Heart, Editorial, Eduard Guasch, Lluís Mont

Date : 15/10/2015

[...]understanding the risk-benefit profile for use of anticoagulation therapies among CKD patients with atrial fibrillation is important to optimize patient outcomes. [...]this prospective cohort ...

Heart, JournalScan

Date : 01/07/2014

Y Blaauw, H J G M Crijns Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands Professor H J G M Crijns, Maastricht University Medical Center, Department of ...

Heart, Education in Heart, Y Blaauw, H J G M Crijns

Date : 01/10/2008

Ruairidh I R Martin1,2, Oksana Pogoryelova1, Mauro Santibáñez Koref1, John P Bourke2, M Dawn Teare3, Bernard D Keavney1,4 1Institute of Genetic Medicine, Newcastle University, Newcastle upon ...

Heart, Arrhythmias and sudden death, Ruairidh I R Martin, Oksana Pogoryelova, Mauro Santibáñez Koref, John P Bourke, M Dawn Teare, Bernard D Keavney

Date : 01/10/2014

Abstract Aims An important decision in the management of patients with atrial fibrillation is whether to adopt a rate or rhythm control strategy. Methods and results We conducted a retrospective ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Carl Hayward, Hitesh C. Patel, Ketna Patel, Carlo Di Mario, Alexander R. Lyon, Syed Y. Ahsan, Edward Rowland

Date : 01/04/2016 Item size : 222623 bytes

Recent data from seven European countries show a much better adherence to evidence and recommendations for oral anticoagulation.1 Interestingly, NOACs were given to younger patients and only to 6% of ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Rocio Hinojar, Jose Julio Jiménez-Natcher, Covadonga Fernández-Golfín, Jose Luis Zamorano

Date : 01/04/2015 Item size : 312462 bytes

While this approach has, e.g. reduced morbidity and mortality in acute coronary artery disease and extended significantly life expectancy in chronic ischaemic heart disease and heart failure, there ...

European Heart Journal, CURRENT OPINION, Paulus Kirchhof, Karin R. Sipido, Martin R. Cowie, Thomas Eschenhagen, Keith A.A. Fox, Hugo Katus, Stefan Schroeder, Heribert Schunkert, Silvia Priori

Date : 07/12/2014 Item size : 581991 bytes

Despite the high prevalence, mortality, and cost of HF-PEF, large phase III international clinical trials investigating interventions to improve outcomes in HF-PEF have yielded disappointing ...

European Heart Journal, Clinical update, Michele Senni, Walter J. Paulus, Antonello Gavazzi, Alan G. Fraser, Javier Díez, Scott D. Solomon, Otto A. Smiseth, Marco Guazzi, Carolyn S. P. Lam, Aldo ...

Date : 21/10/2014 Item size : 851996 bytes

Patients with AF are reported to have a five-fold increased risk of stroke; moreover, compared with the other identified risk factors for stroke (hypertension, heart failure, and coronary heart ...

Europace, Review, Jean-Pierre Bassand

Date : 01/03/2012 Item size : 404682 bytes